Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

37.07
+1.022.83%
Post-market: 37.07-0.0050-0.01%19:37 EDT
Volume:2.33M
Turnover:86.11M
Market Cap:22.80B
PE:29.30
High:37.15
Open:36.55
Low:36.33
Close:36.05
52wk High:40.17
52wk Low:23.62
Shares:615.00M
Float Shares:576.00M
Volume Ratio:0.35
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.83
PE(LYR):24.12

Loading ...

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 23

Genmab : TD Cowen Raises to Buy from Hold; Raises Target Price to $43 from $32

THOMSON REUTERS
·
Jul 22

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 18

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 16

Genmab's Darzalex Generates $4.21 Billion in Q2 Net Trade Sales

MT Newswires Live
·
Jul 15

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)

TIPRANKS
·
Jul 15

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

TIPRANKS
·
Jul 13

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 11

Genmab A/S Stock Falls Wednesday, Outperforms Market

Dow Jones
·
Jul 09

Exchange-Traded Funds Lower, Equity Futures Mixed Amid Caution Over Chip Sector Outlook

MT Newswires Live
·
Jul 07

Genmab Secures EU Approval for Drug Combination Intended for Relapsed or Refractory Follicular Lymphoma

MT Newswires Live
·
Jul 07

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 04

Genmab is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 02

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 02

Abbvie, Genmab Blood-cancer Drug Has Competitive Profile

Dow Jones
·
Jun 30

Investors See European Pharma Stocks as Funding Source for AI Trades

Dow Jones
·
Jun 30

Guggenheim Reaffirms Their Buy Rating on Genmab (GMAB)

TIPRANKS
·
Jun 30